T he development of artificial metalloenzymes is a rapidly expanding field, with design strategies ranging from the modification of natural metalloenzymes through to complete de novo design (Fig. 1a ) [1] [2] [3] [4] [5] [6] [7] . Of these, the anchoring strategy, in which a synthetic catalyst is attached to a protein scaffold, has drawn much attention as it allows the reactivity of organometallic catalysts to be harnessed in a biocompatible and (stereo)selective protein environment [8] [9] [10] . In contrast to covalent anchoring, non-covalent anchoring does not rely on reactive functional groups for bond formation, and hence it allows the individual components, in particular the catalytic site and the protein scaffold, to be optimized independently, before the artificial enzyme is assembled and further optimized as a whole 8, 11, 12 . This advantage of non-covalent anchoring has been exploited extensively, mainly by utilizing the streptavidin-biotin affinity pair 8, [13] [14] [15] [16] , while enzyme-inhibitor and myoglobin-haem combinations [17] [18] [19] have also been explored. While these affinity pairs benefit from the enormous binding strength that cooperative non-covalent interactions can confer, their potential for controlled reversibility has not yet been accomplished. Yet, anchoring should be a reversible process that allows the anchor to be detached when required. Hence, for modularly designed artificial enzymes to reach their full potential, a strong but reversible anchoring process is required that enables both the controlled assembly and disassembly of the components. Controlled reversibility would allow the recycling of both protein scaffold and artificial metal cofactor. The controlled release and replacement of a catalyst should enable exciting new applications in biosensing and (micro)fluidic devices, especially when the protein scaffold is immobilized. Hence, much effort has been devoted to achieving reversibility with biotin derivatives 20 and alternatives 21 or (strept)avidin mutants
T he development of artificial metalloenzymes is a rapidly expanding field, with design strategies ranging from the modification of natural metalloenzymes through to complete de novo design (Fig. 1a ) [1] [2] [3] [4] [5] [6] [7] . Of these, the anchoring strategy, in which a synthetic catalyst is attached to a protein scaffold, has drawn much attention as it allows the reactivity of organometallic catalysts to be harnessed in a biocompatible and (stereo)selective protein environment [8] [9] [10] . In contrast to covalent anchoring, non-covalent anchoring does not rely on reactive functional groups for bond formation, and hence it allows the individual components, in particular the catalytic site and the protein scaffold, to be optimized independently, before the artificial enzyme is assembled and further optimized as a whole 8, 11, 12 . This advantage of non-covalent anchoring has been exploited extensively, mainly by utilizing the streptavidin-biotin affinity pair 8, [13] [14] [15] [16] , while enzyme-inhibitor and myoglobin-haem combinations [17] [18] [19] have also been explored. While these affinity pairs benefit from the enormous binding strength that cooperative non-covalent interactions can confer, their potential for controlled reversibility has not yet been accomplished. Yet, anchoring should be a reversible process that allows the anchor to be detached when required. Hence, for modularly designed artificial enzymes to reach their full potential, a strong but reversible anchoring process is required that enables both the controlled assembly and disassembly of the components. Controlled reversibility would allow the recycling of both protein scaffold and artificial metal cofactor. The controlled release and replacement of a catalyst should enable exciting new applications in biosensing and (micro)fluidic devices, especially when the protein scaffold is immobilized. Hence, much effort has been devoted to achieving reversibility with biotin derivatives 20 and alternatives 21 or (strept)avidin mutants 22 , but the necessary fine tuning of the hydrogen bonding network is challenging.
Siderophores and their cognate periplasmic binding proteins (PBPs) 23 , however, have properties that are well suited to the development of redox-reversible anchoring systems.
Siderophores are produced by microorganisms for the uptake of essential iron(iii) and the iron complexes of siderophores are bound strongly, but reversibly, by their cognate PBPs [24] [25] [26] [27] . Inside the cell, the prominent mechanism for the release of iron from siderophores is reduction of the coordinated iron(iii) to iron(ii). Iron release from the siderophore is facilitated as the resulting iron(ii)-siderophore complexes have a lower thermodynamic stability and are kinetically more labile than their Fe(iii) counterparts 25, 26, 28 . We previously reported that CeuE, an iron-siderophore PBP of Campylobacter jejuni, has high affinity for the iron(iii) complex of the tetradentate siderophore bis(2,3-dihydroxy-benzoyl-l-Ser) (H 5 -bisDHBS, 1, Fig. 1b) , based on the direct metal coordination by two amino acids, His227 and Tyr288 29, 30 . Here we show how this binding mode can be exploited in the development of a redox-switchable iron-siderophore anchor that allows the reversible attachment of synthetic catalysts to CeuE (Fig.  1d) . To monitor whether the synthetic catalyst is turning over in its protein-bound form or, after release, in its unbound state, we chose the transfer hydrogenation of a prochiral imine as the indicator reaction and a racemate-producing organometallic complex as the initial model catalyst. In this system, the interactions of the catalyst with the chiral protein scaffold are reflected in the level of enantioselectivity observed. The choice of catalyst was based on the suitability of similar catalysts in the development of previously reported enantioselective artificial transfer hydrogenases [31] [32] [33] .
Results
Anchor design. As the tetradentate siderophore 1 that we studied initially is challenging to synthesize and hydrolytically unstable, azotochelin, 2 (Fig. 1b) , the siderophore of Azotobacter vinelandii was selected instead. Azotochelin was synthesized as previously described 34 and the affinity of its Fe(iii) complex for CeuE was determined via intrinsic fluorescence quenching (see Supplementary Methods). Its dissociation constant, K d = 4.9 ± 0.4 nM, compares favourably with those reported for artificial enzymes that rely on biotin as an anchoring unit (for example, biotinylated HoveydaGrubbs catalyst⊂ avidin: K d = 6.3 nM) 35 or enzyme inhibitors (for example, sulfonamide-bearing transfer hydrogenation catalyst⊂ human carbonic anhydrase II: K d = 15 nM) 17 . In contrast, the affinities of apo-azotochelin and Fe(ii)-azotochelin for CeuE were too low to be determined in this concentration range (K d = > 1 µ M, Supplementary Fig 1) .
To Supplementary  Fig. 2 ) showed that the four catecholate oxygen donors of azotochelin coordinate to the Fe(iii) centre with the remaining coordination sites being occupied by the donors of His227 and Tyr288 (Fig. 1c) . The carboxylate group in the backbone of the siderophore was deemed appropriate as a conjugation site for the attachment of a catalyst as it remains uncoordinated and points away from the binding site.
The reductively triggered dissociation of the iron(iii) complex of azotochelin was then investigated (Fig. 2) . First, the iron(iii) centre of [Fe ⊂ CeuE was reduced to iron(ii) by addition of sodium dithionite, as evidenced by the bleaching of the broad catecholate-to-iron(iii) charge-transfer band in the electronic absorption spectrum of the complex (wavelength of maximum absorbance, λ max 547 nm, Fig. 2a) . The subsequent addition of an aliquot of the reduced sample (Fig. 2b ) to ferrozine 28, 36 , an iron(ii) indicator, led to the formation of the intensely coloured magenta iron(ii)-ferrozine complex (Fig. 2c,d) , confirming that the reduction to iron(ii) is followed by its dissociation from both the siderophore anchor and CeuE. The re-oxidation of iron(ii) to iron(iii) was achieved by exposure to air and the reassembly of the azotochelin complex was confirmed by the reappearance of its characteristic absorption band. The absorption maximum at 543 nm resembles that of [Fe(AZOTO)] 2− ⊂ CeuE (λ max 547 nm) rather than that of free [Fe (AZOTO)] 2− (λ max 572 nm). Addition of ferrozine to the re-oxidized solution confirmed the absence of residual iron(ii) (Fig. 2e) .
Design, synthesis and characterization of the artificial transfer hydrogenase. Inspired by previous work on artificial transfer hydrogenases (ATHases) by Ward et al. 8 , we initially prepared the Noyori-Ikariya-type catalyst 3, which was able to catalyse the reduction of 4 to (RS)-salsolidine (5), but the slow reaction rate was impractical (Fig. 3b) . In search of a more active catalyst, we considered [Cp*Ir(pyridinesulfonamide)Cl] complexes, which have shown promise in the transfer hydrogenation of ketones and aldehydes with 2-propanol 37, 38 . Encouraged by studies reported by Sadler et al. 39 and Wills et al. 40 , we reasoned that for the reduction of 4 at pH 6.5, an iridium-coordinated amine group would not be required as proton donor. Under these conditions, 4 is protonated and could either react directly with a metal-coordinated hydride 39 or hydrogen bond with the sulfonyl group of the ligand 41 . Hence we replaced the amine group in 3 with a pyridyl group 6 (Fig. 3a) .
Compared with 3, 6 shows a significantly enhanced reaction rate for the reduction of 4 to (RS)-5 ( Fig. 3b) .
To improve the nucleophilicity of the nitrogen atom in 6, a methylene group was inserted to give 9, with which the amide bond formation to produce 10 proceeded in good yields (Fig. 3c) − was obtained by reacting the deprotected conjugate H 5 -11 with iron(iii), followed by iridium(iii).
Finally, CeuE was added to prepare the ATHase, which was characterized by electrospray ionization mass spectrometry (ESI-MS; Supplementary Methods and Supplementary Fig. 3 ). Signals at In view of the envisaged application of the artificial enzyme in asymmetric catalysis, it was of interest to investigate the stereochemistry of the conjugate. In [Fe iii (11) ] by recording circular dichroism spectra, both in the absence and presence of CeuE. In the absence of CeuE, the circular dichroism spectra of both complexes display a positive band between 330 nm and 335 nm and a very weak positive band at around 600 nm (Fig. 4b) , which can be assigned to ligand-based transitions and ligand-to-metal chargetransfer (LMCT) transitions, respectively 44 . As the latter reflect the chirality at the iron(iii) centre, the low intensity of the LMCT band is indicative of a weak asymmetric induction effect exerted by the l-lysine backbone in [ was soaked into a crystal of apo-CeuE (PDB code: 3ZKW) and the structure was determined by X-ray crystallography. Experimental details are provided in the Supplementary Methods. The crystal is in space group P1 with three independent protein chains (A, B and C) in the asymmetric unit. The following description focuses on chain C, which shows the clearest additional electron density in the binding pocket (Fig. 4c,d ).
As seen previously, the azotochelin moiety chelates a Λ -configured iron centre 29, 30 . However, the flexible loop containing His227, which coordinates to the iron in [Fe iii (AZOTO)]
2−
⊂ CeuE, is displaced by the catalyst and the sixth coordination site is occupied by an aqua/hydroxo ligand.
While the azotochelin moiety is well ordered and modelled with full occupancy, the catalyst moiety of [Fe iii (11)Cp*Ir iii ] adopts more than one conformation, evidenced by the anomalous difference map ( Supplementary Fig. 4 ). The major conformation of the catalyst moiety was modelled with an occupancy of 0.6.
The crystal structure of a related iridium catalyst was independently determined (12, Fig. 4e , CCDC: 1551724) in a centric space group that thus contained both enantiomers. The geometric parameters from this structure were used as restraints in the building and refinement of the conjugate complex model. During the modelling of the major conformation, we were encouraged to find that only one enantiomer gave a satisfactory fit to the density. This provides a potential explanation for the observed enantioselectivity of the protein-bound catalyst (vide infra), the protein imposing a preference for one of the two chiral forms. While the electron density is low for the Cp* ring and parts of the catalyst, difference maps confirmed their approximate location ( Supplementary Fig. 5 ). Similar partial occupancies have previously been observed in crystal structures of ATHases with anchored iridium-based catalysts 17, 32 . In [Fe iii (11)Cp*Ir iii ]⊂ CeuE, His227 cannot coordinate to the iron as its access is blocked by the catalyst, and instead appears to lie close to the iridium centre and may well be coordinated to it ( Supplementary Fig. 6 ). If it is coordinated, one of the ligands, most likely His227, is required to dissociate to enable hydride coordination during catalysis, and the flexibility of the loop on which His227 is located may make such a movement possible. There is no indication in the structure of an iridium-bound chloride ion, consistent with the mass spectrometry results. Interestingly, dual anchoring via coordination of a suitably positioned histidine residue to the catalyst was previously reported to enhance the enantioselectivity of a biotin-anchored ATHase 31 . In that study, the catalyst was linked to the biotin anchor through the Cp* ligand and the histidine remains coordinated during the catalytic cycle, with the incoming hydride replacing an iridium-bound chloride ligand instead. − compared with 6 (Table 1 and Fig. 5a ). In addition, the presence of the protein causes a reduction in activity for both 6 and [Fe iii (solv) 2 − is used in the absence of CeuE. Hence, chiral induction by the l-lysine backbone of azotochelin is insignificant. These observations confirm that the siderophore-mediated anchoring to CeuE is required to achieve enantioselectivity, as it positions the catalyst within the chiral environment provided by the protein. To gauge the contribution of the His227 to the enantioselectivity, it was replaced with a non-coordinating residue, as previously described 43 . The mutation of His227 to alanine (H227A) resulted in a clear drop in the e.e. to approximately 3%, while the catalytic rate increased to around one-third of the free conjugate. This suggests that whilst His227 impedes the catalysis to a significant extent, potentially by coordinating to the iridium centre, it is responsible for a large portion of the enantioselectivity.
Release of the siderophore-anchored catalyst and ATHase reassembly. Sodium dithionite was added to [Fe iii (11)Cp*Ir iii ]⊂ CeuE until the bleaching of the catecholate-to-iron(iii) charge-transfer band confirmed that the reduction had gone to completion (λ max 547 nm, Fig. 6a-c and Supplementary Fig. 7 ). The separation of the reductively released iron(ii) and the azotochelin-catalyst conjugate from CeuE was achieved by centrifugal microfiltration (details in the Supplementary Methods). Once SDS-polyacrylamide gel electrophoresis (PAGE; Supplementary Fig. 8a ), circular dichroism (Supplementary Fig. 8b ) and ultraviolet-visible spectroscopy confirmed that the recovered CeuE was intact, correctly folded and free of residual azotochelin-catalyst conjugate, [Fe iii (11) − . The activity of the reassembled ATHase was confirmed in subsequent catalytic runs. While the % conversion obtained with the recycled protein was slightly lower than that seen pre-recycling, the stereo-directing effect of the protein was fully restored (e.e. 32%, Fig. 6d ).
The recovery of the azotochelin-catalyst conjugate from the spin filtrate proved challenging due to adsorption by the semipermeable membrane of the cut-off filter. If required, it is possible to partially recover functional catalyst conjugate by extraction of the reduced artificial enzyme solution with ethyl acetate, followed by high-performance liquid chromatography (HPLC; recovery yields: iridium-bound azotochelin-catalyst conjugate. 11%; H 5 -11, 15%; Supplementary Methods and Supplementary Fig. 9 ). However, the extraction with ethyl acetate leads to the precipitation of CeuE and the recovery yield is low. Consequently, the current system allows the recycling of either the protein or a fraction of the conjugate, but not both at the same time.
Further recycling studies are underway and are directed towards siderophore-catalyst conjugates, in which the catalyst is linked to the siderophore through the Cp ligand. The aim is to not only improve the solubility profile of the conjugates, but also allow His227 to remain coordinated during the catalytic cycle and thus to increase the catalytic activity and e.e.
Conclusions
We have identified azotochelin and CeuE as a siderophore-protein combination that allows an iridium-based transfer hydrogenation catalyst to be anchored both strongly and reversibly, via the iron complex of the siderophore. Proof of concept was demonstrated by means of a prototype ATHase, [Fe iii (11)Cp*Ir iii ]⊂ CeuE, which was characterized by mass spectrometry, circular dichroism spectroscopy and X-ray crystallography and shown to catalyse the reduction of a prochiral imine with reproducible enantioselectivity. The crystal structure of the ATHase revealed that His227 is located close to the catalytic iridium(iii) centre. This observation, together with the fact that its replacement with alanine results in a clear decrease in e.e. strongly suggests that His227 forms a key part of the chiral binding pocket responsible for the enantioselectivity.
As the product obtained in the absence of the protein scaffold is essentially racemic, the transfer hydrogenation reaction provided a means of differentiating the CeuE-bound state of the siderophorecatalyst conjugate from its unbound state. This demonstrates that the insertion of the conjugate into the protein scaffold can be controlled via the oxidation state of the iron. In the presence of iron(iii), the azotochelin-based anchor binds strongly to CeuE, but the anchor can be released via reduction of iron(iii) to iron(ii).
In this way, catalytic centres that have lost activity, for example, due to poisoning or decomposition, could easily be removed and then replaced by a new active catalyst, thereby allowing the protein scaffold to be reused. In addition, there is scope for the introduction of other catalysts with similar piano-stool structures. Hence, we propose that the redox-switchable nature of ferric-azotochelin anchoring, if combined with a modular approach to enzyme design, could extend the range of applications in which artificial enzymes can be utilized. If, for example, CeuE was to be immobilized on a surface, controlled redox switching, either electrochemically or chemically, could be used to reversibly bind a chosen catalyst where and when required, allowing biosensor arrays or discovery flow systems to be developed. Catalyst exchange via redox switching would thus allow the re-patterning and re-programming of a given platform. Opportunities to widen the scope of the reversible anchoring approach include the exploration of similar tetradentate siderophores, initially in combination with other catecholate siderophorebinding proteins, in particular those with iron-coordinating Tyr and His residues 29, 30 . Looking forward, it would be of interest to engineer suitable amino acid combinations into the binding pockets of unrelated proteins. Therefore, our feasibility study is expected to open up interesting new prospects in artificial enzyme research.
Methods
Compound synthesis and characterization. General methods.
H and

13
C NMR spectra were recorded on a Jeol ECS 400 (400 MHz for 1 H, 100 MHz for 13 C) at ambient temperature. Chemical shifts are reported relative to residual solvent peaks and coupling constants (J) are given in Hertz. High-resolution ESI mass spectra were recorded on a Bruker microTOF electrospray mass spectrometer. Infrared (IR) spectra were recorded on a PerkinElmer Spectrum Two (ATIR), covering a wavenumber range of 4,000-450 cm . Elemental analyses were carried out on an Exeter CE-440 elemental analyser. The circular dichroism spectroscopic measurements were performed on a Jasco J810 circular dichroism spectropolarimeter at 20 °C under constant nitrogen flush and the specific rotation was recorded on a Jasco DIP-370 digital polarimeter. Fluorescence spectra were recorded on a Hitachi F-4500 fluorescence spectrophotometer. Analytical thin-layer chromatography (TLC) was performed using Merck silica gel 60 F253 aluminium-backed plates using specified solvent systems and visualized using a Chromato-vue Model CC-10 ultraviolet lamp. Flash column chromatography was carried out using Fluka Silica, pore size 60 Å, 220-440 mesh, 35-75 μ m.
Compound 8. 4-Cyanobenzenesulfonyl chloride (7, 11 mmol, 2.21 g) suspended in 100 ml of dichloromethane was added dropwise to a stirred solution of 2-(aminomethyl)pyridine (10 mmol, 1 ml) and triethylamine (20 mmol, 2.8 ml) in 250 ml dichloromethane cooled on ice. The solution was allowed to warm to room temperature over 4 h and stirred overnight. The solution was concentrated to approximately 100 ml and washed with water (3 × 30 ml) followed by brine (1 × 25 ml). The organic layer was dried with MgSO 4 and the solvent dried in vacuo. The crude product was recrystallized with hot ethyl acetate using hexanes as an anti-solvent to afford 8 as a beige powder (2.13 g, 7.84 mmol, 78%). added over approximately 5 h (gas evolution on addition) and the solution was refluxed overnight under a nitrogen atmosphere. This was followed by addition of an extra 5 ml of dry methanol before the solution was slowly cooled to room temperature. Deionized water (33 mmol, 0.6 ml) was added and the mixture stirred for 1 h before the flask was opened to atmosphere. MgSO 4 was added, and the suspension filtered. The solvent was removed in vacuo to yield a crude white solid, which was suspended in EtOAc:MeOH (2:1, v/v) and applied to a short silica plug, washed with EtOAc (100%), and the product eluted with EtOAc:MeOH (2:1, v/v). The solvent was removed in vacuo to yield 9 in form of a white solid (0.531 g, 1.91 mmol, 70% Compound 10. 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (0.5 mmol, 90 µ l) was added to a stirred solution of Bn 4 -azotochelin (0.5 mmol, 0.389 g, prepared in accordance twith the literature 46 ), triethylamine (1 mmol, 0.139 ml) and hydroxybenzotriazole (0.05 mmol, 6.75 mg) in 5 ml dry DMF. Subsequently 9 (0.5 mmol, 0.138 g) was added and the solution was stirred overnight with a drying tube attached. The DMF was removed in vacuo and the crude product was suspended in 75 ml ethyl acetate and washed with 0.1 M HCl (1 × 25 ml), saturated NaHCO 3 (1 × 25 ml) and brine (1 × 25 ml). The organic layer was dried over MgSO 4 and the solvent dried in vacuo. The crude product was purified by column chromatography (silica gel, 100% EtOAc) to afford the pure 10 as an off-white powder (0.244 g, 0.235 mmol, 47%).
TLC ( Compound 11. Reaction glassware was prepared by soaking in 6 M HCl for 4 h, followed by potassium hydroxide in EtOH to remove any residual metal ions. To a solution of 10 (0.09 mmol, 93 mg) dissolved in dry ethanol, palladium hydroxide 20% on carbon (0.1 mmol, 70 mg) was added. The vessel was purged with nitrogen, followed by hydrogen and then filled with hydrogen. The reaction was stirred vigorously overnight. The remaining hydrogen was released and the suspension filtered using a Whatman glass microfiber filter GF/F. The organic solvent was removed in vacuo to yield 11 as a beige solid (57.7 mg, 0.085 mmol, 95%).
TLC (EtOAc, 100%): R f = 0; ) was dissolved in 2 ml dichloromethane and added to a stirred solution of 8 (0.2 mmol, 0.0550 g) in 1 ml dichloromethane. Sodium hydroxide (0.1 ml, 2.0 M methanolic) was added to give a pale orange/yellow solution, which was stirred for 1 h. The solution was filtered and the solvent removed in vacuo to give an orange solid, which was washed with diethyl ether (3 × 5 ml) to yield 12 as a pale orange solid (0.0743 g, 0.11 mmol, 55%). Supplementary Fig. 10 .
Site-directed mutagenesis and purification of CeuE. The plasmid encoding N-terminal hexahistidine-tagged CeuE used in previous studies 30 was isolated from Escherichia coli NovaBlue competent cells (Merck Chemicals) using a Wizard Genomic DNA Purification kit (Promega). Site-directed mutagenesis was performed in a 25 µ l reaction containing Kod Hot start DNA polymerase (0.5 U), dNTPs (200 µ M), MgSO 4 (1 mM), plasmid DNA (1 ng), forward primer (5′ -CTGTTCCAGGGACCAGCATTGTTGCCTATTAGTA) (400 µ M), reverse primer (5′ -TACTAATAGGCAACAATGCTGGTCCCTGGAACAG) (400 µ M), and 1 × Kod PCR buffer. The PCR cycle was performed at 94 °C for 2 min, followed by 18 cycles of 94 °C for 30 s, 60 °C for 30 s, and 72 °C for 3 min, followed by a final extension at 72 °C for 5 min. The template DNA was removed by addition of 2 µ l of CutSmart buffer and 1 µ l DpnI (20 U µ l −1 ) to 20 µ l of PCR reaction followed by incubation at 37 °C for 2 h. The final PCR product was transformed into NovaBlue competent cells. Mutagenesis was confirmed by isolation and sequencing of the plasmid from several bacterial colonies using a T7 promoter primer (Eurofins MWG operon). Protein from mutated plasmids was expressed in E. coli BL21 (DE3) cells grown in Luria-Bertani broth with 50 µ g ml −1 kanamycin. Cultures were grown at 37 °C with shaking at 200 r.p.m. When the OD 600 reached 0.6, protein expression was induced by addition of 1 mM IPTG to cultures. Cultures were further incubated for 4 h and cells were harvested by centrifugation. Cell pellets were resuspended 1:10 (w/v) in 50 mM Tris-Cl pH 7.5, 500 mM NaCl, 10 mM imidazole with cOmplete EDTA-free Protease Inhibitor Cocktail (Roche Diagnostics) followed by sonication. The lysate was cleared of insoluble material by centrifugation at 38,000 × g, 4 °C for 40 min followed by filtration of supernatant through a 0.4 µ m syringe filter. The filtered sample was loaded onto a 5 ml HisTrap FF Ni-chelating column (GE healthcare) and eluted using an imidazole gradient (final concentration of 500 mM) on a BioRad NGC chromatography system. The N-terminal histidine tag was removed by addition of 2 mg of 3C protease to 100 mg of eluate, followed by dialysis in 3 l of 40 mM Tris-Cl pH 7.5, 150 mM NaCl at 4 °C for 16 h. Residual traces of Histagged CeuE and 3C protease were removed from the sample by repeating the Ni-affinity purification step. Protein samples were dialysed twice in 2 l of 100 mM MES buffer pH 6, 500 mM NaCl at 4 °C for 20 h. Protein was concentrated to 60 mg ml −1 in an Amicon centrifugation filter unit (Millipore), separated into 50 µ l aliquots and stored at − 80 °C. Protein purity and integrity was confirmed by SDS-PAGE and ultraviolet circular dichroism.
CeuE with a mutation at the histidine at position 227 to alanine was prepared as described in a previous study 43 . Catalytic activity testing. General. 6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline was purchased from Acros. Analytical HPLC measurements were performed on a Shimadzu HPLC system (Prominence) equipped with a LC-20AD pump, SIL-20A autosampler, DGU-20AS degasser, CTO-20AC column oven, CBM-20A communication bus module and SPD-M20A diode array detector using a Lux Cellulose-4 column (Phenomenex, 250 mm × 4.6 mm, 5 µ m) with the specified eluent gradient.
Preparation of the artificial transfer hydrogenase [Fe
Stock solutions. MES/formate buffer: 6.40 g of 2-morpholin-4-ylethanesulfonic acid monohydrate (MES monohydrate) and 10.20 g of sodium formate were dissolved in 40 ml water and the pH adjusted by addition of NaOH, before the solution volume was finalized at 50 ml (final concentration 0.6 M MES, 3 M formate). Substrate: 0.2053 g of 6, 7-dimethoxy-1-methyl-3,4-dihydroisoquinoline was dissolved in 2 ml of MES/formate buffer (final concentration 0.5 M). Compound 11: 3.39 mg of 11 was dissolved in 500 µ l DMF (final concentration 10 mM). Glutathione: 76.8 mg of glutathione was dissolved in 1 ml of water (final concentration 250 mM). Catalyst.: 10 mM stock solutions of the required catalysts were prepared in situ by mixing [IrCp*Cl 2 ] 2 with the appropriate ligand in DMF.
General procedure. 6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline (50 mM) and 0.125 mM catalyst in 0.6 M MES pH 6, 3 M sodium formate incubated at 40 °C with a magnetic stirrer set to 400 r.p.m. Reactions were initiated by addition of the substrate and 25 µ l samples were taken at selected time points and quenched by adding to 975 µ l of l-glutathione (50 µ l of 250 mM l-glutathione stock diluted in 300 µ l water and 625 µ l MeOH). Samples were left to stand for 1 h at 4 °C before being filtered through 0.22 µ m nylon membranes. Reaction progression was monitored via HPLC (see HPLC method below for further details). Peaks that represented substrate and product with an absorbance at 285 nm were integrated and used to calculate normalized product percentages. Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article Data availability. Experimental details of circular dichroism spectroscopic measurements (Fig. 4b) , intrinsic fluorescence quenching titrations (Fig. 4a) , mass spectrometry measurements, crystal structure determinations (Fig. 4c-e) and reversibility studies (Figs. 2 and 6) The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 
Software and code
Policy information about availability of computer code
Data collection
Data were collected by applying the software associated with the respective instrumentation used, as specified in the SI. No custom software or code was used.
Data analysis
Protein crystallography: data integration was carried out with XDS through Xia2 and the data were merged with Aimless. Computations were carried out with CCP4, MOLREP, REFMAC and COOT. Small molecule crystallography: face-indexed absorption corrections were applied using SCALE3 ABSPACK scaling. OLEX2 was used for overall structure solution, refinement and preparation of computer graphics. Within OLEX2, the algorithms used for structure solution were direct methods using SHELXS-97 and refinement by full-matrix leastsquares used SHELXL-97 within OLEX2. Spectra were plotted and analyzed with OriginPro 2017 and Microsoft Excel 2010. CeuE average mass was calculated using the ExPASy online calculator. Binding constants were calculated using DynaFit. NMR spectra were processed with ACD/Spectrus Processor 2016.1.1.
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information. All studies must disclose on these points even when the disclosure is negative.
Sample size
The number of repeats for the catalytic tests were chosen according to best practice in the field.
Data exclusions No data were excluded from the analysis, unless an obvious error/spillage/fault was encountered during the experiment.
Replication
The published experiments were independently reproduced at least three times. There are no findings that could not be reproduced.
Randomization Sample selections and combinations were random.
Blinding
Blinding was not relevant to this study due to the nature of the experiments and small sample numbers involved.
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